New book by Larry Connors Click here Improve your trading - See how
- Sigma Tau Finanziaria Spa, 10% Owner: reported buying $1,000.00K
- Cavazza Paolo, 10% Owner: reported buying $1,000.00K
- Cavazza Claudio, 10% Owner: reported buying $1,000.00K
Over the last four weeks insiders at DOR BioPharma, Inc. (DORB.OB) have bought more than $3.00M:
- Sigma Tau Finanziaria Spa, 10% Owner: bought $1,000.00K increasing total holdings by 9%
- Cavazza Paolo, 10% Owner: bought $1,000.00K increasing total holdings by 9%
- Cavazza Claudio, 10% Owner: bought $1,000.00K increasing total holdings by 9%
For a current, real-time summary of DORB.OB insider activity, visit http://www.form4oracle.com/company/dor-biopharma-inc-dorb.ob?id=5011
About Form4Oracle
Form4Oracle, LLC specializes in distributing insider trading information published by the SEC, making it accessible and actionable for all types of investors. To learn more about how tracking insider trading activity can improve your investment returns, visit http://www.form4oracle.com.
About DOR BioPharma, Inc.
DOR BioPharma, Inc., a biopharmaceutical company, engages in the research and development of oral therapeutic products intended for areas of unmet medical needs and biodefense vaccines in the United States and internationally. The company operates through two segments, BioTherapeutics and BioDefense. The BioTherapeutics segment develops orBec, an orally administered corticosteroid, which exerts a potent and local anti-inflammatory effect in the mucosal tissue of the gastrointestinal tract; Oraprine, an oral suspension of azathioprine; and LPE and PLP systems for delivery of water-insoluble drugs. The BioDefense segment offers RiVax, ricin toxin vaccine, a heat stable toxin that is isolated and purified from the bean of the castor plant; and BT-VACC, the Botulinum toxin, a poisonous natural substance, which causes acute, symmetric, and descending flaccid paralysis due to its action on peripheral cholinergic nerves. DOR BioPharma, Inc. was founded in 1987 and is headquartered in Ewing, New Jersey.
--------------------------------------------
The companies referenced in this report have not approved the statements made in this report. This report contains statements that imply risks and uncertainties. This material is for informational reporting purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Form4Oracle is not a licensed broker, broker dealer, market maker, investment banker, investment adviser, analyst or underwriter and is not compensated in this regard.
Please consult your broker to understand investing benefits and risks and prior to purchasing any securities mentioned herein.
CONTACT: Kimberly Sutton, Form4Oracle Tel: +1 312 315 5077 e-mail: kimberly@form4oracle.com WWW: http://www.form4oracle.com
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
